New Rochelle, NY, August 17, 2015--During the last 10 years, the number of articles in peer-reviewed journals worldwide about clinical trials of yoga therapy to alleviate disease-related symptoms increased 3-fold. This large-scale analysis of published research studies spanning 46 years, 29 countries, and more than 28,000 study participants is published in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on The Journal of Alternative and Complementary Medicine website until September 17, 2015.
Pamela Jeter, PhD, Johns Hopkins University (Baltimore, MD) and Maryland University of Integrative Health (Laurel, MD), Sat Bir Khalsa, PhD, Harvard Medical School (Boston, MA), and coauthors found that yoga therapy was most often used for the treatment of mental health, cardiovascular disease, and respiratory disease. They report their findings in the article "Yoga as a Therapeutic Intervention: A Bibliometric Analysis of Published Research Studies from 1967 to 2013." This study was supported in part by the Patanjali Yogpeeth Trust (PYP USA).
About the Journal
The Journal of Alternative and Complementary Medicine is a monthly peer-reviewed journal published online with open access options and in print. The Journal provides observational, clinical, and scientific reports and commentary intended to help healthcare professionals and scientists evaluate and integrate therapies into patient care protocols and research strategies. Complete tables of content and a sample issue may be viewed on The Journal of Alternative and Complementary Medicine website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Alternative and Complementary Therapies, Medical Acupuncture, and Journal of Medicinal Food. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.